Twin Bridge Capital Partners LLC

10/10/2022 | Press release | Archived content

Twin Bridge Invests in Alcanza Clinical Research

Twin Bridge Invests in Alcanza Clinical Research

Washington, DC, October 03, 2022, ̶ To stay ahead of the urgent needs of equitable healthcare, Martis Capital, a leading middle market healthcare fund, is excited to announce its investment in Alcanza Clinical Research. Founded in December 2021 and named for the Spanish word "reach," Alcanza is a clinical research site network platform dedicated to creating a sustainable and inclusive clinical trial environment for all.

To read more about the investment, please visit here

Twin Bridge Capital Partners LLC published this content on October 10, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 15, 2026 at 06:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]